These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19404014)

  • 21. [From FAB classification to WHO classification of tumors of hematopoietic and lymphoid tissue].
    Yatomi Y
    Rinsho Byori; 2012 Jun; 60(6):550-2. PubMed ID: 23061109
    [No Abstract]   [Full Text] [Related]  

  • 22. [From FAB and REAL to WHO as comprehensive classification for hematopoietic and lymphoid tissues].
    Tomonaga M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():233-40. PubMed ID: 17474416
    [No Abstract]   [Full Text] [Related]  

  • 23. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.
    Cazzola M
    Blood; 2016 May; 127(20):2361-4. PubMed ID: 27069255
    [No Abstract]   [Full Text] [Related]  

  • 24. 2016 WHO Classification update-What's new in lymphoid neoplasms.
    Hsi ED
    Int J Lab Hematol; 2017 May; 39 Suppl 1():14-22. PubMed ID: 28447410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors].
    Polyatskin IL; Artemyeva AS; Krivolapov YA
    Arkh Patol; 2019; 81(3):59-65. PubMed ID: 31317932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors].
    Baram DV; Asaulenko ZP; Spiridonov IN; Krivolapov YA
    Arkh Patol; 2023; 85(4):24-31. PubMed ID: 37530187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological diagnosis and classification of lymphoma: present status in China].
    Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):289-90. PubMed ID: 20654149
    [No Abstract]   [Full Text] [Related]  

  • 28. The 2004 World Health Organization classification of pituitary tumors: what is new?
    Al-Shraim M; Asa SL
    Acta Neuropathol; 2006 Jan; 111(1):1-7. PubMed ID: 16328527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
    Leonard JP; Martin P; Roboz GJ
    J Clin Oncol; 2017 Aug; 35(23):2708-2715. PubMed ID: 28654364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.
    Turner JJ; Morton LM; Linet MS; Clarke CA; Kadin ME; Vajdic CM; Monnereau A; Maynadié M; Chiu BC; Marcos-Gragera R; Costantini AS; Cerhan JR; Weisenburger DD
    Blood; 2010 Nov; 116(20):e90-8. PubMed ID: 20699439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Informatics Approaches to Address New Challenges in the Classification of Lymphoid Malignancies.
    Jordan J; Goldstein JS; Jaye DL; Gurcan M; Flowers CR; Cooper LAD
    JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30637363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction to the Fifth Edition of the World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues.
    Naresh KN; Medeiros LJ;
    Mod Pathol; 2023 Dec; 36(12):100330. PubMed ID: 37716508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
    Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
    Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms.
    Choi SM; O'Malley DP
    Ann Diagn Pathol; 2018 Dec; 37():67-74. PubMed ID: 30308438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Classification from FAB to WHO in myeloid malignancies].
    Watanabe R; Kizaki M
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():287-92. PubMed ID: 23133969
    [No Abstract]   [Full Text] [Related]  

  • 36. Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice.
    Jaffe ES; Barr PM; Smith SM
    Am Soc Clin Oncol Educ Book; 2017; 37():535-546. PubMed ID: 28561690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The classification of lymphomas: a new beginning or the end of an era?
    Jack AS
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S13-8. PubMed ID: 12734688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
    Anastasi J
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lymphoma of the central nervous system].
    Gabryel P; Szymaś J; Biczysko W
    Neuropatol Pol; 1979; 17(4):535-44. PubMed ID: 514517
    [No Abstract]   [Full Text] [Related]  

  • 40. The 2016 revision of the WHO classification of lymphoid neoplasms: The clinician's view.
    Sorigue M; Sancho JM
    Med Clin (Barc); 2018 Jan; 150(2):64-66. PubMed ID: 28545953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.